BDC Stock Recent News

We take a look at the action in business development companies through the third week of March and highlight some of the key themes we are watching. BDCs saw a 2% total return this week, but March is shaping up to be the worst month since late 2023. A recent Bloomberg article discussed PSEC culture and outsider status.

This is my first BDC portfolio monthly performance review article. The good news is that the portfolio has done its job, outperforming the two BDC benchmarks - PBDC and BIZD. Yet, on an absolute basis, the portfolio is slightly down.

Ares Capital's diverse portfolio and strong dividend yield of 8.7% make it a stable and attractive investment for reliable supplemental income. Despite trading at a premium to NAV, ARCC's valuation is reasonable compared to peers, with low non-accrual rates and consistent capital allocation to new investment activity. ARCC's portfolio growth and strategic investments in senior secured debt provide downside protection and potential for capital appreciation.

Part 2 of this article compares GBDC's recent dividend per share rates, yield percentages, and several other highly detailed (and useful) dividend sustainability metrics to 11 other BDC peers. This includes a comparative analysis of GBDC's cumulative undistributed taxable income ratio, percentage of floating-rate debt investments, recent weighted average annualized yield, and weighted average interest rate on outstanding borrowings. GBDC's “base” dividend sustainability remains strong. When comparing/analyzing all metrics (including additional metrics not mentioned), GBDC is currently deemed to be appropriately valued as a Hold.

Capital Southwest offers a high dividend yield and strong underwriting but is riskier than larger peers like ARCC due to its size and business model. Despite solid fundamentals and attractive valuation, economic uncertainties suggest holding off on new investments in CSWC to avoid potential sharp declines. CSWC's diversified portfolio, primarily in first-lien senior secured loans, provides some protection, but the company remains vulnerable to economic downturns.

CCAP experienced a stock price drop of over 10% due to uncertainty about its income potential and value proposition. CCAP's portfolio is 90% first-lien debt, with 85% in non-cyclical industries, ensuring priority in capital collection and defensive positioning. Diversification is key: top 10 investments hold only 15% of the portfolio, with an average position of 0.5% and low non-accruals.

NEW YORK--(BUSINESS WIRE)--Investcorp Credit Management BDC, Inc. (NASDAQ: ICMB) (“ICMB” or the “Company”) announced its financial results today for its fiscal period ended December 31, 2024. HIGHLIGHTS On March 20, 2025, the Company's Board of Directors (the “Board”) declared a distribution of $0.12 per share for the quarter ending March 31, 2025, payable in cash on May 16, 2025, to stockholders of record as of April 25, 2025. During the quarter, ICMB made investments in two new portfolio comp.

REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced it will present data from the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancers at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois.

Crescent Capital BDC, Inc. offers a 10.6% dividend yield and trades at an 11% discount to book value, making it a compelling income investment. CCAP's portfolio is conservatively managed with 90% senior secured loans and strong private equity sponsorship, with low non-accruals. Despite lower base rates, CCAP maintains solid returns, supported by a healthy balance sheet and stable NAV/share, with management expecting increased deal activity.

PennantPark Floating Rate Capital, PFLT, is a completely different BDC than its related arm PNNT. In my last piece that was issued in August 2024, I made it clear that the dividend is safe, even though the conclusion might be different seeing 103% coverage level. The recent financials confirm my thesis on many fronts.